GPR25: Key Regulator of Pain Perception and Disease (G2848)

GPR25: Key Regulator of Pain Perception and Disease

GPR25, also known as GPR25 receptor, is a G protein-coupled receptor located on the surface of many different types of cells in the body. It is a key regulator of pain perception and has been implicated in a number of diseases, including cancer, neurodegenerative disorders, and autoimmune diseases.

GPR25 is a transmembrane receptor, which means that it spans the cell membrane and is responsible for communicating with the cell body, or intracellular space. It is composed of a extracellular portion, known as the N-terminus, and an intracellular portion, known as the C-terminus. The N-terminus is involved in the formation of the complex between the receptor and its ligand, while the C-terminus is involved in the signaling of the receptor.

GPR25 is a G protein-coupled receptor, which means that it is a member of a family of proteins that transmit signals from the cell surface to the cell body. The G protein-coupled receptor system is a large and diverse family of transmembrane proteins that play a key role in many different processes in the body, including signaling pathways, ion channels, and signaling pathways.

GPR25 is involved in a number of different signaling pathways, including pain perception, neurodegenerative disorders, and autoimmune diseases. It is a key regulator of pain perception, which means that it is involved in the perception of pain and the regulation of pain sensitivity. GPR25 has also been shown to be involved in the regulation of neurodegenerative disorders, such as Alzheimer's disease and Parkinson's disease, as well as autoimmune diseases, such as rheumatoid arthritis and multiple sclerosis.

GPR25 has also been shown to play a key role in the regulation of inflammation. It is a potent inhibitor of the production of inflammatory cytokines, which are important mediators of inflammation in the body. GPR25 has also been shown to play a key role in the regulation of immune responses, which is important for maintaining the immune system's ability to fight off infections and diseases.

GPR25 is also a potential drug target. Researchers have identified several potential drugs that can inhibit the activity of GPR25 and have shown that these drugs can be effective in treating a variety of diseases, including cancer, neurodegenerative disorders, and autoimmune diseases. GPR25 has also been shown to be a potential biomarker, which means that it can be used as a diagnostic tool for certain diseases.

GPR25 is a complex protein that is involved in a number of different signaling pathways. It is a potential drug target and a potential biomarker, and its role in the regulation of pain perception, neurodegenerative disorders, and autoimmune diseases is still being fully understood. Further research is needed to fully understand the role of GPR25 in the regulation of pain perception and other biological processes, and to identify new treatments for a variety of diseases.

Protein Name: G Protein-coupled Receptor 25

Functions: Orphan receptor

More Common Targets

GPR26 | GPR27 | GPR3 | GPR31 | GPR32 | GPR33 | GPR34 | GPR35 | GPR37 | GPR37L1 | GPR39 | GPR4 | GPR42 | GPR45 | GPR50 | GPR52 | GPR55 | GPR6 | GPR61 | GPR62 | GPR63 | GPR65 | GPR68 | GPR75 | GPR75-ASB3 | GPR78 | GPR79 | GPR82 | GPR83 | GPR84 | GPR84-AS1 | GPR85 | GPR87 | GPR88 | GPR89A | GPR89B | GPRACR | GPRASP1 | GPRASP2 | GPRASP3 | GPRC5A | GPRC5B | GPRC5C | GPRC5D | GPRC5D-AS1 | GPRC6A | GPRIN1 | GPRIN2 | GPRIN3 | GPS, PLAT and transmembrane domain-containing protein | GPS1 | GPS2 | GPS2P1 | GPSM1 | GPSM2 | GPSM3 | GPT | GPT2 | GPX1 | GPX1P1 | GPX2 | GPX3 | GPX4 | GPX5 | GPX6 | GPX7 | GPX8 | GRAMD1A | GRAMD1B | GRAMD1C | GRAMD2A | GRAMD2B | GRAMD4 | GRAMD4P2 | GRAMD4P5 | GRAMD4P7 | Granzyme | GRAP | GRAP2 | GRAPL | GRAPL-AS1 | GRASLND | GRB10 | GRB14 | GRB2 | GRB7 | GREB1 | GREB1L | GREM1 | GREM1-AS1 | GREM2 | GREP1 | GRHL1 | GRHL2 | GRHL3 | GRHL3-AS1 | GRHPR | GRIA1 | GRIA2 | GRIA3